Pedersen and Maggie Fick COPENHAGEN (Reuters) -Wegovy-maker Novo Nordisk lowered its full-year profit and sales forecasts ...
LONDON (Reuters) -Novo Nordisk said on Wednesday it had agreed a price under the U.S. Medicare scheme for semaglutide, the ...
Novo Nordisk's new CEO said he was confident in the company's pipeline of obesity drugs, but that buying Metsera would allow ...
The financial results show top-line sales growth in the first nine months of the year of 12% to DKK 230 billion ($35.4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback